Summary of Purpose
The prevalence of AF, which is tachyarrhythmia, is approximately 2% of the entire population and 5% of the population at the age of 60 or older. AF is the cause of approximately 20% of all events of ischemic stroke, and patients with AF are known to be at 6 to 10% risk of ischemic stroke per year. Patients with valvular AF are known to have a higher incidence of stroke than patients with nonvalvular AF. However,...Read More →
The following dates are available for this trial. Trial information last updated on 8 January 2018.
|1 Dec 2016||29 Nov 2016||1 Dec 2019||1 Dec 2019||1 Jan 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Duk-Hyun Kang, M.D.
- Kee-Joon Choi, M.D.